Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             36 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acute venous thromboembolism in patients with brain cancer: clinical course Becattini, Cecilia

7 6 p.
artikel
2 Anti-emicizumab antibodies do not cross-react with mim8 in vitro Valsecchi, Carla

7 6 p.
artikel
3 Avatrombopag for adult chronic primary immune thrombocytopenia: a randomized phase 3 trial in China Mei, Heng

7 6 p.
artikel
4 Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry Agosti, Pasquale

7 6 p.
artikel
5 Citrullination of α2-antiplasmin is unlikely to contribute to enhanced plasmin generation in COVID-19 pathophysiology Kangro, Kadri

7 6 p.
artikel
6 Coagulation factors II, V, VII, IX, X and XI and mortality – a cohort study Yap, Eng Soo

7 6 p.
artikel
7 Congenital thrombophilia in East-Asian venous thromboembolism population: a systematic review and meta-analysis Zhu, Xi-Jie

7 6 p.
artikel
8 Editorial Board
7 6 p.
artikel
9 Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial Smilowitz, Nathaniel R.

7 6 p.
artikel
10 Health-related quality of life is impaired in bleeding disorders of unknown cause: results from the Vienna Bleeding Biobank Mehic, Dino

7 6 p.
artikel
11 Issue Information
7 6 p.
artikel
12 Letter in response to Othman & Favaloro “Comparison of two ways of performing ristocetin-induced platelet agglutination (RIPA) mixing study for diagnosis of type 2B VWD” Soleimani, Reza

7 6 p.
artikel
13 Lipoprotein(a) and risk of cognitive impairment in Black and White Americans: the Reasons for Geographic and Racial Differences in Stroke cohort Arce Rentería, Miguel

7 6 p.
artikel
14 Long-term outcomes of prophylaxis with a recombinant factor VIII Fc or recombinant factor IX Fc in patients with hemophilia previously treated on demand Álvarez-Román, María-Teresa

7 6 p.
artikel
15 Lower mortality with andexanet alfa vs 4-factor prothrombin complex concentrate for factor Xa inhibitor-related major bleeding in a U.S. hospital-based observational study Dobesh, Paul P.

7 6 p.
artikel
16 Management of surgery in persons with hemophilia A receiving emicizumab prophylaxis: data from a national hemophilia treatment center Cohen, Omri

7 6 p.
artikel
17 Measuring ADAMTS-13 activity to diagnose thrombotic thrombocytopenic purpura: a novel, fast fiber-optic surface plasmon resonance immunoassay Bonnez, Quintijn

7 6 p.
artikel
18 Mim8, a novel factor VIIIa mimetic bispecific antibody, shows favorable safety and pharmacokinetics in healthy adults Persson, Paula

7 6 p.
artikel
19 Neutralizing antidrug antibody to emicizumab in patients with severe hemophilia A: Case report of a first noninhibitor patient and review of the literature Kizilocak, Hande

7 6 p.
artikel
20 New insight into the traditional model of the coagulation cascade and its regulation: illustrated review of a three-dimensional view Troisi, Romualdo

7 6 p.
artikel
21 No von Willebrand factor domains other than A1 are involved in type 2B von Willebrand disease: what the p.R924Q and p.A2178S variants teach us Casonato, Alessandra

7 6 p.
artikel
22 Overuse and underuse of thromboprophylaxis in medical inpatients Kocher, Barbara

7 6 p.
artikel
23 Plasma tissue-type plasminogen activator is associated with lipoprotein(a) and clinical outcomes in hospitalized patients with COVID-19 Zhang, Ziyu

7 6 p.
artikel
24 Progestin-only contraception is first line for sickle cell disease: a comment on “Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias.” Pecker, Lydia H.

7 6 p.
artikel
25 Prophylaxis with a recombinant factor VIII Fc in hemophilia A: long-term follow-up on joint health, efficacy, and safety from phase 3 studies in children and adults Konkle, Barbara A.

7 6 p.
artikel
26 Psychometrics of the patient-reported outcomes measurement information system measures in hemophilia: the applicability of the pediatric item banks Teela, Lorynn

7 6 p.
artikel
27 Recombinant factor IX Fc for major surgery in hemophilia B: factor IX plasma activity levels and effective hemostasis Shapiro, Amy D.

7 6 p.
artikel
28 Reply to “Comment on: A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays” Colpani, Paola

7 6 p.
artikel
29 Role of heat shock protein 47 in platelet glycoprotein VI dimerization and signaling AlOuda, Sarah K.

7 6 p.
artikel
30 Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays Bouck, Emma G.

7 6 p.
artikel
31 Thromboembolism in nephrotic syndrome: controversies and uncertainties Parker, Kathrine

7 6 p.
artikel
32 Tissue factor-heparanase complex: intracellular nonhemostatic effects Ghanem, Shorook

7 6 p.
artikel
33 T2 mapping magnetic resonance imaging of cartilage in hemophilia Brakel, Benjamin A.

7 6 p.
artikel
34 Toward non-factor therapy in hemophilia: an antithrombin insensitive Gla-domainless factor Xa as tissue factor pathway inhibitor bait Dagher, Marie-Claire

7 6 p.
artikel
35 Tranexamic acid in a mouse model of cerebral amyloid angiopathy: setting the stage for a novel stroke treatment approach Liu, Zikou

7 6 p.
artikel
36 Venous thromboembolism prophylaxis for hospitalized adult patients: a survey of US health care providers on attitudes and practices Lam, Barbara D.

7 6 p.
artikel
                             36 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland